Protara Therapeutics Inc (TARA)
2.91
+0.02
(+0.69%)
USD |
NASDAQ |
May 03, 16:00
2.89
-0.02
(-0.69%)
Pre-Market: 20:00
Protara Therapeutics Price to Book Value: 0.487 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.487 |
| May 02, 2024 | 0.4837 |
| May 01, 2024 | 0.4903 |
| April 30, 2024 | 0.4987 |
| April 29, 2024 | 0.5188 |
| April 26, 2024 | 0.4895 |
| April 25, 2024 | 0.5104 |
| April 24, 2024 | 0.4719 |
| April 23, 2024 | 0.5021 |
| April 22, 2024 | 0.5104 |
| April 19, 2024 | 0.4418 |
| April 18, 2024 | 0.4602 |
| April 17, 2024 | 0.4569 |
| April 16, 2024 | 0.477 |
| April 15, 2024 | 0.4753 |
| April 12, 2024 | 0.5021 |
| April 11, 2024 | 0.5171 |
| April 10, 2024 | 0.5339 |
| April 09, 2024 | 0.5389 |
| April 08, 2024 | 0.574 |
| April 05, 2024 | 0.6075 |
| April 04, 2024 | 0.6728 |
| April 03, 2024 | 0.6862 |
| April 02, 2024 | 0.6878 |
| April 01, 2024 | 0.6928 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.6711 |
| March 27, 2024 | 0.6694 |
| March 26, 2024 | 0.6945 |
| March 25, 2024 | 0.6677 |
| March 22, 2024 | 0.6728 |
| March 21, 2024 | 0.6527 |
| March 20, 2024 | 0.6744 |
| March 19, 2024 | 0.6694 |
| March 18, 2024 | 0.6694 |
| March 15, 2024 | 0.6159 |
| March 14, 2024 | 0.5975 |
| March 13, 2024 | 0.6108 |
| March 12, 2024 | 0.5975 |
| March 11, 2024 | 0.5975 |
| March 08, 2024 | 0.6359 |
| March 07, 2024 | 0.6371 |
| March 06, 2024 | 0.6571 |
| March 05, 2024 | 0.6221 |
| March 04, 2024 | 0.7319 |
| March 01, 2024 | 0.7652 |
| February 29, 2024 | 0.7585 |
| February 28, 2024 | 0.7436 |
| February 27, 2024 | 0.8034 |
| February 26, 2024 | 0.7802 |
| February 23, 2024 | 0.7003 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1661
Minimum
Nov 22 2023
5.478
Maximum
Jun 02 2020
0.748
Average
0.4247
Median
Jan 18 2022
Price to Book Value Benchmarks
| AngioDynamics Inc | 1.148 |
| Regulus Therapeutics Inc | 8.190 |
| Bio-Path Holdings Inc | 4.017 |
| Outset Medical Inc | 1.290 |
| AN2 Therapeutics Inc | 0.6124 |
Price to Book Value Related Metrics
| Price | 2.91 |
| Earnings Yield | -122.7% |
| Market Cap | 33.27M |